Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125745141 | 12574514 | 1 | I | 20160509 | 20160718 | 20160720 | 20160720 | EXP | FR-AFSSAPS-PC20160413 | FR-GLAXOSMITHKLINE-FR2016GSK103045 | GLAXOSMITHKLINE | 80.09 | YR | F | Y | 0.00000 | 20160720 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125745141 | 12574514 | 1 | PS | Zelitrex | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 20487 | |||||||||||
| 125745141 | 12574514 | 2 | SS | ALDARA | IMIQUIMOD | 1 | Topical | UNK | 0 | ||||||||||
| 125745141 | 12574514 | 3 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | U | 0 | ||||||||||
| 125745141 | 12574514 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 125745141 | 12574514 | 5 | SS | IMBRUVICA | IBRUTINIB | 1 | Oral | UNK | 0 | ||||||||||
| 125745141 | 12574514 | 6 | SS | MABTHERA | RITUXIMAB | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 125745141 | 12574514 | 7 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
| 125745141 | 12574514 | 8 | C | AMLOR | AMLODIPINE BESYLATE | 1 | 5 MG, VA | U | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125745141 | 12574514 | 1 | Product used for unknown indication |
| 125745141 | 12574514 | 2 | Neoplasm malignant |
| 125745141 | 12574514 | 3 | Product used for unknown indication |
| 125745141 | 12574514 | 4 | Product used for unknown indication |
| 125745141 | 12574514 | 5 | Lymphoma |
| 125745141 | 12574514 | 6 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125745141 | 12574514 | OT |
| 125745141 | 12574514 | HO |
| 125745141 | 12574514 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125745141 | 12574514 | Diarrhoea | |
| 125745141 | 12574514 | Dizziness | |
| 125745141 | 12574514 | Dry mouth | |
| 125745141 | 12574514 | Euphoric mood | |
| 125745141 | 12574514 | Fatigue | |
| 125745141 | 12574514 | Headache | |
| 125745141 | 12574514 | Insomnia | |
| 125745141 | 12574514 | Nausea | |
| 125745141 | 12574514 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125745141 | 12574514 | 2 | 20160503 | 20160524 | 0 | |
| 125745141 | 12574514 | 5 | 201505 | 20160527 | 0 | |
| 125745141 | 12574514 | 6 | 201503 | 20160527 | 0 |